SJPHS Cardiac Cath Lab/Hybrid OR
In early June, 2011, St. John Providence Health System opened Michigan’s first Hybrid Cardiovascular Operating Room, located at St. John Hospital and Medical Center. The Gretchen C. Valade Hybrid Cardiovascular Operating Room and Minimally Invasive Structural Heart Program is a gift from Gretchen C. Valade, who donated $3 million for the OR costs, and an additional $2 million to purchase a da Vinci® Si HD Surgical System, the latest and most advanced robotic surgical device and a key addition to the new Hybrid Cardiovascular Surgical OR.
A Grosse Pointe Farms resident, Mrs. Valade is Chair of Carhartt, Inc., CEO of Mack Avenue Records; and owner of the Dirty Dog Jazz Café. She has supported many projects and programs at SJH&MC over the years, including the expansion and renovation, the Valade Healings Arts Center, The Suites, Hospice and Emergency Center. Mrs. Valade has a true interest in the progressive technology that allows us to offer the latest procedures to our patients and uphold our leadership position in cardiac care. We are extremely thankful for her foresight and generosity.
As the anchor of a new $5 million Minimally Invasive Structural Heart Program at SJH&MC, the laboratory will be used to perform advanced non-surgical and minimally invasive surgical cardiovascular procedures, including small incision, minimally invasive aortic valve replacement surgery and percutaneous mitral valve repair and percutaneous aortic valve replacement.
These types of procedures are the wave of the future for tertiary cardiac care centers. It was imperative that we add this Hybrid Cardiovascular OR to maintain our leadership position in cardiac care and offer the most up-to-date procedures to our patients.
The new lab is one of the most versatile treatment centers in the country. In addition to treating valve disease with either non-surgical or minimally invasive surgical procedures, the lab will allow for sophisticated diagnostic tests and a full range of invasive and non-invasive therapeutic procedures including angioplasty, the implantation of pacemakers and internal defibrillators. The lab is also be equipped for traditional cardiac surgery.
Using the da Vinci Si, the heart care team will perform a wide range of complex procedures through minimally invasive one-centimeter incisions. In the future, the new robotic system will be used for surgical heart procedures such as minimally invasive heart bypass surgery and mitral-valve repair. It will also be utilized by other clinical services including oncology, gynecology and urology.